<code id='757A0AD11B'></code><style id='757A0AD11B'></style>
    • <acronym id='757A0AD11B'></acronym>
      <center id='757A0AD11B'><center id='757A0AD11B'><tfoot id='757A0AD11B'></tfoot></center><abbr id='757A0AD11B'><dir id='757A0AD11B'><tfoot id='757A0AD11B'></tfoot><noframes id='757A0AD11B'>

    • <optgroup id='757A0AD11B'><strike id='757A0AD11B'><sup id='757A0AD11B'></sup></strike><code id='757A0AD11B'></code></optgroup>
        1. <b id='757A0AD11B'><label id='757A0AD11B'><select id='757A0AD11B'><dt id='757A0AD11B'><span id='757A0AD11B'></span></dt></select></label></b><u id='757A0AD11B'></u>
          <i id='757A0AD11B'><strike id='757A0AD11B'><tt id='757A0AD11B'><pre id='757A0AD11B'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:73811
          People waiting in line, standing in between red rope. -- first opinion coverage from STAT
          Adobe

          Health care providers and health insurance companies are closing the books on their third quarters, and one major question continues to hang over them: How much care is everyone actually getting, now that Covid-19 isn’t scaring so many away from doctors and hospitals?

          The short answer, according to financial analysts and the companies themselves: It appears people continue to fill prescriptions, see their doctors, and get recommended surgeries.

          advertisement

          For health insurers, those trends mean they will have to deposit more money into the bank accounts of providers — perhaps more than they predicted.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          Anesthesiologist group: stop taking Ozempic before surgery
          Anesthesiologist group: stop taking Ozempic before surgery

          EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

          read more
          Sanofi CEO defends move to abandon profit guidance, boost research
          Sanofi CEO defends move to abandon profit guidance, boost research

          SanofiCEOPaulHudsonCarolynKaster/APLONDON—SanofiCEOPaulHudsononWednesdaydefendedhiscompany’srecentmo

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Biotech incubator Curie.Bio graduates its first startup

          ChristophLengauer,co-founderandCSOofCurie.BioVanessaLeroyforSTATCurie.Bio,thenewbiotechinvestmentfir